This week's letters to the editor address our 'law and order president,' square dancing and Ron Johnson's support of a book.
2hon MSN
Seeing thyroid cancer in a new light: When AI meets label-free imaging in the operating room
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...
A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...
Multidimensional intervention for patients with lung cancer incorporates rehabilitation, psychosocial support, nutrition guidance, health promotion, and safety surveillance. Multidimensional ...
News Medical on MSN
UH pharmacology professor wins $900,000 grant to develop a dual-function nanodrug for cancer
Accelerating advancements in cancer prevention and cures, Wei Gao, assistant professor of pharmacology at the University of Houston College of Pharmacy, has received a $900,000 grant from the Cancer ...
Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...
News-Medical.Net on MSN
New trial aims to improve both survival and quality of life for men with advanced prostate cancer
The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...
What's a Cancer like? Just ask the friends and family in their lives — you won't find a more devoted person. As a fourth sign of the zodiac and the first water sign in the celestial lineup, Cancers ...
SurvivorNet on MSN
Targeted therapy in a shot: New approval for EGFR-mutated lung cancer can improve day-to-day life for patients
Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Amgen Inc. has acquired cancer drug developer Dark Blue Therapeutics Ltd. in a deal worth as much as $840 million, expanding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results